State Street Corporation 13D and 13G filings for Allogene Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-23 10:02 am Sale | 2023-12-31 | 13G | Allogene Therapeutics, Inc. ALLO | STATE STREET CORP STT | 2,427,284 1.440% | -6,739,124 (-73.52%) | Filing |
| 2023-02-03 3:52 pm Purchase | 2022-12-31 | 13G | Allogene Therapeutics, Inc. ALLO | STATE STREET CORP STT | 9,166,408 6.360% | 9,166,408 (New Position) | Filing |